These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
560 related articles for article (PubMed ID: 28359621)
41. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437 [TBL] [Abstract][Full Text] [Related]
42. Seroepidemiology of varicella in Hangzhou, China in the vaccine era. Xu Y; Liu S; Che X; Liu Y; Zhang X; Du J; Zhang X; Wang J; Xu E Hum Vaccin Immunother; 2018; 14(10):2464-2471. PubMed ID: 30019992 [TBL] [Abstract][Full Text] [Related]
43. The effect of vaccination on the epidemiology of varicella zoster virus. Edmunds WJ; Brisson M J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726 [TBL] [Abstract][Full Text] [Related]
44. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection. Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630 [TBL] [Abstract][Full Text] [Related]
45. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine. Watson B J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388 [TBL] [Abstract][Full Text] [Related]
46. Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination. Habermehl P; Lignitz A; Knuf M; Schmitt HJ; Slaoui M; Zepp F Vaccine; 1999 Feb; 17(7-8):669-74. PubMed ID: 10067672 [TBL] [Abstract][Full Text] [Related]
47. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection. Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506 [TBL] [Abstract][Full Text] [Related]
48. Prospects for use of a varicella vaccine in adults. Hardy IR; Gershon AA Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261 [TBL] [Abstract][Full Text] [Related]
49. Immunity to varicella zoster virus in young Israeli adults. Avrahami-Heller Y; Cohen D; Orr N; Slepon R; Ashkenazi I; Danon YL Isr Med Assoc J; 2000 Mar; 2(3):196-9. PubMed ID: 10774265 [TBL] [Abstract][Full Text] [Related]
50. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults. Koturoglu G; Kurugol Z; Turkoglu E Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681 [TBL] [Abstract][Full Text] [Related]
51. Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study. Mirinaviciute G; Barlinn R; Gjeruldsen Dudman S; Flem E PLoS One; 2019; 14(8):e0221084. PubMed ID: 31408478 [TBL] [Abstract][Full Text] [Related]